Susquehanna International Group, LLP Enochian Biosciences Inc Call Options Transaction History

Susquehanna International Group, LLP

8 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q2 2024 Aug 15, 2024	BUY	N/A	17,700 Added 110.63%	33,700 $155,000
Q1 2024 May 07, 2024	SELL	N/A	-7,600 Reduced 32.2%	16,000 $73,000
Q4 2023 Feb 14, 2024	SELL	$4.3 - $4.7 $96,320 - $105,280	-22,400 Reduced 48.7%	23,600 $108,000
Q3 2023 Nov 14, 2023	BUY	$0.0 - $4.46 $0 - $205,160	46,000 New	46,000 $205,000
Q3 2022 Nov 14, 2022	SELL	$1.7 - $2.86 $77,860 - $130,988	-45,800 Reduced 54.01%	39,000 $71,000
Q2 2022 Aug 15, 2022	BUY	$1.93 - $8.73 $133,556 - $604,116	69,200 Added 443.59%	84,800 $164,000
Q4 2021 Feb 14, 2022	SELL	$6.71 - $12.55 $99,308 - $185,740	-14,800 Reduced 48.68%	15,600 $114,000
Q3 2021 Nov 15, 2021	BUY	$4.56 - $7.88 $138,624 - $239,552	30,400 New	30,400 $205,000

14M

33.7K

Ticker ENOB
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 52,950,000
Market Cap $244M
Description
Enochian Biosciences, Inc., a pre-clinical stage biotechnology company, engages in the research and development of pharmaceutical and biological products for the human treatment of human immunodeficiency virus (HIV), hepatitis B virus (HBV), influenza and coronavirus infections, and cancer. The company's lead candidate includes ENOB-HV-01 for au...

Get notified when there are updates to the investment portfolio of Susquehanna International Group, LLP, based on Form 13F filings with the SEC.

Stay updated on Susquehanna International Group, LLP with notifications on news.